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ABSTRACT 
Despite over hundred years of study, the intestinal pathogen Vibrio cholerae still 
causes epidemic outbreaks in areas of the world. The endemic areas include India, Asia, 
Africa, the Mediterranean, and more recently, South and Central America, Mexico and the 
United States (Faruque et a/, 1998). This Gram-negative bacterium cplonizes the human 
intestine and causes potentially fatal diarrhoeal disease- the Cholera. 
A number of genes associated with the virulence of Vibrios had so far been identified 
by researchers of cholera. These genes are gaining popularity among researchers especially in 
the manipulation of them towards the production of an effective cholera vaccine. 
In this research, however, the recA gene was the center of interest. It was reported by 
Ghosh et al (1985) that the Vibrio cholerae have a RecA system that is analogous to the 
Escherichia coli RecA system. The RecA protein is the central enzyme for homologous 
recombination, DNA strand exchange, and DNA repair mechanism (Kuzminov, 1999). In the 
development of live attenuated, oral cholera vaccine, the mutation of recA gene was strongly 
recommended by some researchers to render the vaccine strains recombination deficient 
(Goldberg and Mekalanos, 1986; Taylor et al, 1994; Kenner et al, 1995; Kaper et al, 1994; 
Boyd and Waldor, 1999). Hence, the general approach of study is to mutate the recA gene in 
existing vaccine strain (VCUSM-2) to stabilize and prevent the strain from further acquiring 
the undesirable gene when released to the environment. 
The study began with a deletional mutation in the 1.2kb Vibrio cholerae recA gene 
previously cloned onto the vector, pTOP02.1. The EstEll was recognized as the unique 
restriction enzyme site which existed twice in the middle of Vibrio cholerae recA gene at the 
location of 71 Obp and 782bp. Upon restriction with EstEll, a small fragment of gene with the 
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size of 72bp was deleted. The sticky overhang was polished and this was followed by a self-
blunt end ligation of the linearized plasmid. The deletional mutation of recA gene produced a 
+ 1 frameshift mutation starting from the ligation junction to the down stream of recA gene. 
As a result a stop codon was introduced at 748bp of the gene, and hence results in a truncated 
recA gene product. 
The successfully mutated Vibrio cholerae recA gene was then subcloned onto the 
pBluescriptiiSK before it was transferred onto the pCVD442, a conjugatable suicide plasmid 
for conjugation with the cholera vaccine strain, VCUSM-2. 
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INTRODUCTION 
The history of cholera 
The modem history of cholera was recorded back in 1817, when cholera spread out of 
India and began the first of its seven pandemics. For the past centuries, the cholera bacterium 
had spread worldwide to the Middle East, South and Central America, Mexico and the United 
States (Faruque et a/., 1998; Faruque et a/., 2002; Reidl and Klose, 2002; Pourshafie et a!., 
2002). Cholera is a boarder-less disease for no country can defy the invasiveness of cholera 
into its territory, let it be the underdeveloped, developing or well-developed countries. 
It has been generally accepted that there are seven recorded pandemics of cholera in 
history. The first four pandemics were not known of their exact etiological agent, as it could 
not be recognized at that moment of time. The last three pandemics, however, were 
recognized to be the V. cholerae serogroup 01 (Faruque et a/., 2002; Reidl and Klose, 2002). 
The seventh pandemic which began in 1961 in Indonesia was caused by the 01 
serogroup of Vibrio cholerae and it continues until today (Lan and Reeves, 2002). It was not 
until 1992, large outbreaks of cholera began in Bangladesh and India which were found to be 
caused by a previously unrecognized serogroup of Vibrio cholerae. The bacterium resembled 
the Vibrio cholerae 01 in both the cultural and biochemical characteristics, producing the 
same virulence cholera toxin but did not agglutinate with the 01 antisera. The isolation of this 
new strain of vibrios were designated as 0139, synonym as the Bengal strains. Since then, its 
presence had been reported from 11 countries in the South-East Asia region and became a 
threat of cholera outbreaks alongside with the Vibrio cho/erae 01 (Faruque et al., 2002). 
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The bacterium 
The cholera vibrios are Gram-negative, slightly curved rods that belong to the family 
Vibrionaceae. They are facultatively anaerobic, non-spore forming, and motile with a single 
polar flagellum. Vibrio cholerae can grow well in alkaline condition up to pH10 but its 
growth is retarded when the pH drops below 6.0. 
Vibrio cholerae is classified serologically based on the heat-stable somatic '0' antigen 
on the surface of bacterium. By agglutination test with specific antisera, the Vibrio cholerae is 
classified into different serogroups. Currently more than 200 '0' serogroups has been 
described. The 01 serogroup can be further divided into different serotypes: Ogawa, Inaba 
and Hikojima based on specific antigenic formulas. However, there is no recognizable 
serotype given to the 0139 serogroup so far. 
It is the 01 or 0139 strain which often found to be responsible for major outbreaks. 
The ability of the 01 and 0139 serogroup to produce the cholera toxin (CT) is an essential 
determinant of its virulence. Only those which carry the ctx gene elements are capable of 
producing the cholera toxin and this ctx gene is actually acquired from a bacteriophage, the 
CTX<I> (Reidl and Klose, 2002; Faruque eta/., 1998). 
Epidemiology, pathogenesis and impact of cholera outbreaks in the world 
Outbreaks of cholera had been well documented by the World Health Organization 
(WHO). In year 2002, 40 countries worldwide had officially reported 123,986 cholera cases 
and claimed 3, 763 deaths (Chaignat, 2004). However, the actual statistical value of morbidity 
and mortality may be under reported due to surveillance limitations. 
Cholera i s o ften associated with poor sanitation, overcrowding population, war and 
famine, all of which are often linked to the third world countries. However, cases of cholera 
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are no longer restricted to the third world countries. As the bacteria exist as natural inhabitant 
of aquatic ecosystem, they are capable of invading the human system via contaminated food 
or drink without boundaries (Reidl and Klose, 2002) 
Upon uptake of contaminated food or water, the bacteria adhere and penetrate into the 
mucosal lining of intestine. It then colonized the ileum and secreted the cholera toxin. The B 
subunit ofthe cholera toxin binds to the ganglioside GM1 receptor on the mucosal cells to 
allow the entrance of A subunit of cholera toxin into the cell. Activation of the A subunit will 
increase the level of intracellular cAMP and causes prolonged hypersecretion of water and 
electrolytes, resulting in massive watery diarrhea (Reidl and Klose, 2002). The disease is 
characterized by typical clinical symptoms such as passage of rice-watery stool, followed by 
vomiting, dehydration, hypovolemic shock and acidosis. Those inflicted lose gallons of water 
in just one day, and death could easily occur if treatment is not given promptly. 
Despite the human suffering, cholera outbreak also causes panic, disrupting the social 
and economic structure as well as deterring the development of affected communities. For 
example, the cholera outbreaks in Peru in 1991 had cost the country USD770 million due to 
food embargoes and adverse effects on tourism (Chaignat, 2004). 
Diagnosis, treatment and control measures 
The clinical diagnosis is suggested by strikingly severe, watery diarrhea with 
additional signs and symptoms as described above. An immediate wet mount of watery stool 
sample or hanging-drop preparation of rectal swab in alkaline peptone water may reveal the 
characteristic' darting' motility of Vibrio cho/erae under light microscope. This movement 
can be stopped by specific antisomatic antibody. The gold standard laboratory diagnosis of 
cholera is by performing the rectal swab culture on the Thiosulfate-Citrate-Bile salt-Sucrose 
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(TCBS) medium whereby the sucrose fermenting Vibrio cholerae appeared as large, yellow, 
smooth, round and glistening colonies against a bluish-green background. Other methods like 
slide agglutination test with specific antiserum, fermentation test (oxidase positive), 
fluorescent antibody test, and the more recent PCR based rapid detection techniques have also 
been applied in specialized laboratory to detect Vibrio cholerae. 
Treatment of cholera involves the rapid replacement of fluid and ion loss by 
intravenous infusion of the isotonic solutions. To bypass the need for sterility or intravenous 
invasion, the oral rehydration salt (ORS) can be administered orally in the less severe cases of 
cholera. The ORS is a simple regimen to revert the loss of water and electrolytes in severely 
diarrheal patient. It is especially useful for the third world countries where medical devices 
are inadequate. Besides, ORS is also convenient for immediate home treatment which is often 
life saving to a cholera patient. It was reported that a simple ORS treatment can reduced the 
mortality rate of cholera up to ten fold (Faruque et al., 1998). Most antibiotics play no 
significant value in treatment of cholera although some, for instance tetracycline may shorten 
the duration of diarrhea and reduced fluid loss. 
The WHO had recommended the improvement of water supply and sanitation as the 
most sustainable approach to prevent cholera. In tenns of human behaviour in relation to 
personal hygiene and proper food handling, community health education plays an important 
role in this aspect (Chaignat, 2004). Preventative measure by using vaccine against cholera is 
gaining popularity for the prospective protection of population at risk in the endemic areas. It 
is believed that the oral cholera vaccine has greater values over the parenteral vaccine as it 
mimics the natural invasion of the bacteria into human body to elicit a mucosal immune 
response. 
6 
The importance of recA gene 
The recA gene produces a 38 kDa RecA protein. The RecA protein is the key enzyme 
which involves in homologous recombination by catalyzing the pairing of a foreign ssDNA 
into the complementary region of dsDNA in a bacterium. On the other hand, it is also a co-
protease for activating the LexA protein in self-repair mechanism when there is injury in the 
bacterial DNA. Under normal circumstances, LexA binds to the SOS boxes of DNA which 
represses the expression of both the lexA and recA gene. Upon injwies to the DNA, the RecA 
protein will be triggered and it functions as a co-protease to cleave the LexA (Vierling et al., 
2001). 
The recA gene homologs had been cloned from many different bacterial species and 
the sequence as well as function of recA gene was found out to be highly conserved among 
bacteria (Vierling et a/., 2001). The ultimate involvement of recA gene in homologous 
recombination and DNA repair mechanism is perhaps the most striking features that 1 ured 
scientists into the study of recA gene in many microorganisms. 
One drawback of the live oral vaccine is the doubt of its safety after being shed by the 
vaccinees to the environment. It is feared that these vaccine strains, although attenuated in the 
first place might somehow regain the virulence gene from the wild type strains in 
environment and further undergoes undesirable mutation (Taylor DN et al., 1994; Kenner JR 
eta/., 1995; Kaper JB eta/.). The concern becomes a string that leads researchers into the 
study of recA gene in V.cholerae. By the mutation of recA gene in V.cho/erae, it is hoped that 
the mutation will render the organism homologous recombination deficient. It will then 
become an environmentally safe vaccine strain that could no longer undergo any natural 
genetic alteration when release to the environment. 
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REVIEW OF LITERATURE 
To manipulate and mutate the recA gene is like a safety measure in the development of 
live cholera vaccine. The recA mutant will prevent the vaccine strains from picking up 
possible virulence genes when release to the environment. Since the discovery of recA system 
in Vibrio cholerae dated back in 1985 by Ghosh and colleagues, they had created a new 
window in the cholera research. In their study, the researchers had designed a probe from the 
recA gene of Escherichia coli and then performed the Southern blot hybridization with the 
Vibrio cholerae genome. This had successfully revealed a complementary sequence which 
bind with the probe. The sequence hence was purported as the possible recA gene of Vibrio 
cholerae. Next, they pursued to examine if the gene had properties of recA proteolytic 
function in SOS response. By using the DNA damaging agent (Furazolidone), the SOS-like 
response (as measured by beta phage induction) was observed. 
Following the discovery of recA gene in Vibrio cholerae, a pilot study of the recA 
gene mutation was carried out by Mekalanos and Goldberg ( 1986). The study was triggered 
when they realized the cholera toxin gene (CTX) was only found in the toxigenic strains but 
not in the non-toxigenic strains of Vibrio cholerae. Besides, this CTX gene existed at multiple 
location of the cholera chromosome and capable of undergoing tandem duplication and 
amplification (Mekalanos, 1983). This indicated active recombination events frequently 
occurred in the Vibrio cholerae and causing it virulence. For further study of this 
recombination event, they tried to mutate the recA gene to produce arecA- Vibrio cholerae 
strain which is deficient in homologous recombination. 
First, they randomly cut the Vibrio cholerae genome into fragments with Sau3A and 
cloned them into the BamHI site of a plasmid, pBR327. This had produced a plasmid-based 
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library oft he Vibrio c holerae genome. The p lasmids were then transformed into a special 
Escherichia coli host to which its recA gene was deleted. By using the complementation 
method, they grown the bacteria in media added with DNA damaging agents, Methyl methane 
sulfonate (MMS). Only the vector which carried the recA gene of Vibrio cho/erae is capable 
of complementing the Escherichia coli host for its resistancy to the MMS. In this way, they 
had successfully isolated the recA gene from the genomic library, and they performed a 4-
base pair insertional mutation into the Xbal site within the recA gene. This had introduced a 
nonsense mutation which leads to the production of a truncated RecA protein. The mutated 
recA was then transferred to the Vibrio cholerae genome by spontaneous recombination. The 
recA- Vibrio cholerae strain was produced and it became susceptible to the damaging effects 
of UV light and was impaired in homologous recombination activity. 
In the s arne year, the t earn presented another paper sequel to the previous research 
mentioned above, on the effect of recA mutation for the cholera toxin gene amplification and 
deletion events (Mekalanos and Goldberg, 1986). Here, they had inserted a kanamycin 
resistant cassette into the ctx 1 oci of Vibrio cholerae. Under normal circumstances, Vibrio 
cholerae is sensitive to kanamycin not more than 150J.1g/ml. However, with the introduction 
of the kanamycin resistant gene, the bacteria spontaneously became highly resistant and 
capable of growing on 3mg/ml of kanamycin in media. When performing a Southern blot 
analysis, they realized that ctx element was amplified up to 20 fold. The same approach was 
repeated for Vibrio cholerae with a mutated recA gene. They then found out that the 
amplification process was completely inhibited in the absence of a functional recA gene. This 
clearly showed that the recA gene had an effect on ctx gene amplification and was essential 
for the process to happen. On the other hand, they had also isolated spontaneous kanamycin 
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sensitive colonies. They noticed that spontaneous deletion of the ctx genes happened in both 
the recA+ and recA- Vibrio cho/erae strains, however it occurred at 21-fold lower in the recA-
strains. 
Another study carried out by Hamood AN and colleagues (1986) had also successfully 
isolated and characterized the Vibrio cholerae recA gene. Their method of recA isolation was 
similar to the study of Mekalanos and Goldberg ( 1986) as described above. The recA gene 
was a 3.6kb fragment restricted from the Vibrio cholerae chromosomal DNA. They then 
performed a DNA hybridization experiment to detect homology between the Escherichia coli 
recA and the Vibrio cholerae recA but failed to prove the homology between them. 
Nevertheless, they had observed that RecA protein from both different species shared a 
common epitope as the antiserum produced against purified Escherichia coli recA cross-react 
with the Vibrio cholerae recA gene. In this study, however, no mutation of the Vibrio 
cholerae recA gene was performed. 
As it moves to 1994, another research team by Stroeher and colleagues had cloned the 
recA gene ofOl Vibrio cholerae. A deletional mutation was then performed in the recA gene 
and the resulting mutant showed typical sensitivity to UV light exposure and DNA damaging 
agents as well as impaired in homologous recombination. They also performed the infant 
mouse cholera model by introducing the animal with Vibrio cholerae recA- strains. They 
concluded that the recA deletion mutant of Vibrio cho/erae do not show altered virulence in 
the animal in causing cholera and hence it is ideal for complementation study. This finding is 
supportive to the mutation of recA gene in production of live cholera vaccine. 
On the contrary, a research group by Kumar et al (1994) had disclaimed the fact by 
saying that recA mutation would indeed reduce the adherence and colonization of Vibrio 
10 
cholerae. Here they constructed a frameshift mutation of the recA gene of both classical and 
El Tor strains of Vibrio cholerae and subsequently filter mating the mutated recA with the 
wild type Vibrio cholerae. When experimenting the adherence and colonization studies of the 
mutated recA in animal model, they found out that the recA mutants shown 65% decrease in 
the adherence of rabbit intestine and marked decrease in the colonization of infant mice 
intestine. 
However, the importance of recA mutation in the production of live vaccines is 
revealed in a study carried out by Kaper and colleagues (1994). The research group had 
produced an attenuated live Vibrio cholerae 01 vaccine strain, namely CVD 1 03-HgR. This 
live vaccine strains had raised the concern of many who question if the bacteria is capable of 
reacquire the virulence gene via horizontal gene transfer. To clear the dark clouds and stamp 
out suspicion, Kaper and colleagues had performed a series of mating experiments under a 
variety of in vivo and in vitro condition to testify the possibility of gene reacquisition in their 
vaccine strains. They mated their vaccine strain CVD 103-HgR with three wild type of Vibrio 
cholerae 01 strains in different biotypes and serotypes. All the wild type strains were marked 
with antibiotic resistant gene. The in vitro mating condition were also varied in terms of 
donor/ recipient ratio (1 0:1 and 1:1 0), broth mating and plate mating, as well as mating in the 
suspension of different water samples from the environment. Of all, none of the in vitro 
mating experiments yielded transconjugants after screening with antibiotic sensitivity. 
On the other hand, the in vivo mating experiment was carried out by inoculation of a 
cocktail of CVD 103-HgR and wild type Vibrio cholerae into the suckling mice model. The 
experiment also showed no transconjugant after a 24-hour in vivo incubation period. Although 
all data showing negative results, the group however did not deny that natural transfer of ctx 
11 
genes into their vaccine strains would never occur. This statement had inadvertently support 
the mutation of recA gene in cholera vaccine development for it will render the vaccine strain 
stable when release into the environment. 
More importantly, this approach will permanently close the door of suspicion among 
the disputing researchers and assure the publics of the safety measure undertaken in the 
genetic manipulations of live vaccine strains. 
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LACUNAE IN THE LITERATURE 
When the Bengal strain of Vibrio cholerae (0139) first emerged in 1992, it was not 
given much attention from researchers who thought it was just another non-0 1 passerby 
which causes occasional cholera-like disease. Not until this Bengal strain began to show its 
persistency in causing large cholera outbreak in parallel with the 01 serogroup, the 
researchers came to realize that the 0139 had determined to stay. The 0139 is now 
considered as the second etiologic agent of cholera by researcher worldwide (Faruque et a!., 
2002). 
Due to the negligence of the 0139 Vibrio cholerae in the earlier time of its 
occurrence, the research carried out on this strain was much as less compared to the 01 strain. 
The research on the recA gene of 0139 Vibrio cholerae is even scarce. So far there is no 
published work on the cloning and mutation of recA gene of the 0139 Vibrio cholerae yet. 
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OBJECTIVE OF THE STUDY 
The objective of study is to perform a deletional mutation on the recA gene of 0139 
Vibrio cholerae and then sub-clone it onto conjugatable suicide plasmid, pCVD442 for the 
use of conjugation with the candidate vaccine strains (VCUSM-2) in future. 
14 
MATERIALS AND METHODS 
1. Simulation with Vector NTI program 
Vector NTI is a versatile bio-informatic tool which functions as a database manager 
for a personal collection of nucleic acid and protein sequence profile. It is widely used as a 
tool for remote and local database searching, virtual cloning, oligonucleotide designing, 
identification of restriction enzyme site, gel electrophoresis modeling etc. 
In this study, the Vector NTI was used to identify the unique restriction enzyme site in 
the Vibrio cholerae recA gene. The entire restriction enzyme available in the database was 
selected. The restriction pattern of recA gene was examined to identify the unique restriction 
enzyme which restricts the recA gene in the middle of its open reading frame while not 
restricting the vector. Following this, a deletional mutation was simulated in the recA gene 
with the unique restriction enzyme site chosen. 
2. Media preparation 
2.1 Preparation of Luria Bertani (LB) agar 
LB agar was prepared by dissolving 15g of tryptone (Merck), 5g of yeast extract 
(Oxoid), lOg of Sodium chloride (Anrresco) and 15g of agar (Amresco) into 750ml of 
deionised distilled water. The pH was adjusted up to 7.0 by using 1M of sodium hydroxide 
and the final volume was made up to lOOOml. It was then autoclaved at 121 OC for 15 minutes 
before pouring into sterile Petri plates with 25ml each. The media was cooled down to 40° c 
before the addition of appropriate antibiotic. The autoclaved media was stored in cool room 
for not more than one month. 
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2.2 Preparation of Luria Bertani (LB) broth 
LB broth was prepared by dissolving 15g of tryptone, Sg of yeast extract and lOg of 
Sodium chloride into 750ml of deionised distilled water. The pH was adjusted up to 7.0 by 
using 1M of sodium hydroxide and the fmal volume was made up to lOOOml. It was then 
aliquoted lOml each into universal bottles and autoclaved at 121 oc for 15 minutes and stored 
at room temperature. 
2.3 Concentration of antibiotics 
The Ampicillin and Kanamycin were two antibiotics used in this study for isolation of 
bacteria host carrying the plasmid with antibiotic resistant gene. They were added into the LB 
agar or broth with the suitable concentration as recommended. 
Table 1: Concentration of antibiotics used in LB agar and LB broth 
Antibiotics Final concentration 
Ampicillin 100 JJg I ml 
Kanamycin 50 JJg I ml 
3. Restriction enzyme digestion 
3.1 Restriction enzyme and its principle 
Restriction enzymes (also known as restriction endonuclease) are isolated from 
bacteria that used them as a defense mechanism against viral infection. They are many 
restriction enzymes available, and each has a specific DNA recognition sequence. Wherever 
this particular sequence occurs along the chromosome, the enzyme cleaves the sugar 
phosphate backbones of DNA and produces fragments. 
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The restriction enzymes used in this study were obtained from Fermentas, USA as 
shown in Table 2 below: 
Table 2: Restriction enzymes used in this study 
Restriction enzymes Cleavage site Optimal buffer Optimal 
temperature 
EcoRI 5' ... G .. A.AIJC ... 3' EcoRI unique 37°C 
3' ... CTTAA 0 ... 5' buffer 
BstEII 5' ... Q .. QINA~C ... 3' Buffer o+ 37°C 
3' ... CCANTGiG ... 5' 
san 5' ... G!TCGAC ... 3' Buffer o+ 37°C 
3' ... c·f\acr1a ... 5' 
Sac I 5' ... qA.G.G.I~C ... 3' Sacl unique 37°C 
3' ... 0TCGAG ... 5' buffer 
3.2 Methodology 
The restriction digestion of DNA was performed in a 0.5ml tube. The reaction mixture 
was prepared by adding the following reagents as shown in Table 3. The volume was made up 
to 20Jll and mixed well before incubated at 37°C for 2 to 4 hours. Upon completion of 
digestion, the restriction pattern was studied by loading the sample in agarose gel 
electrophoresis. When double digestion was performed, the most appropriate buffer as 
recommended by the manufacturer was used. 
Table 3 : Preparation of the restriction digestion reaction mix 
Contents Volume 
Sterile deionised distilled water 15.0 Jll 
lOX buffer 2.0 J.LI 
Restriction enzyme 1.0 Jll 
DNA 2.0 Jll 
TOTAL 20.0 J.d 
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3.3 T4 DNA polymerase treatment 
Following restriction digestion of DNA, the T4 DNA polymerase enzyme (Fermentas, 
USA) was used to polish the sticky end of restriction product in order to convert it into a blunt 
end product. This was done by first heat inactivation of the restriction digestion mixture, 
followed by the addition of 1Jll ofT4 DNA polymerase and 0.2Jll of dNTPs (10 mM). It was 
then incubated at 16°C (the lower compartment of refrigerator) for 20 minutes followed by 
heat inactivation at 65°C for 15 minutes. 
4. Agarose gel electrophoresis 
4.1 Principle of agarose gel electrophoresis 
The DNA product from restriction analysis or Polymerase Chain Reaction (PCR) can 
be visualized by agarose gel electrophoresis. Electrophoresis is a process of separating 
molecules based on their size and charge in an electric field. The support medium used is a 
thin gel made up of agarose. 
When the agarose polymerized, it forms a matrix with holes in between the 
interlocking fibers. This allows the DNA to sieve through the gel when electrical current is 
applied. Due to the phosphate group in DNA, it is negatively charged in the electric field and 
hence it moves from cathode to anode. The velocity of movement for a DNA molecule will 
depend on its size. The smaller molecule moves faster than the larger molecule as it can sieve 
through the gel matrix easily whilst the larger molecule will have hindered movement when 
passing through the small holes in gel. 
The concentration of agarose gel used in this study was 0.8%. This concentration may 
vary depends on the desired resolution power to visualize the bands. 
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4.2 Preparation of SOX Tris Acetate EDTA (T AE) stock 
A SOX stock solution of T AE was prepared by dissolving 121 g of tris-base in 
deionised distilled water and adding 50ml of 0.5M EDTA and 28.5ml glacial acetic acid. 
Deionised distilled water was added to make a final volume of 5 OOml and stored at room 
temperature. A working solution (IX T AE) was prepared by diluting 20ml of stock solution 
with 980ml deionised distilled water. 
4.3 Preparation of 0.8°/o T AE agarose gel 
By using the weighing scale, 0.8g of agarose gel (Pronadisa) was weighed and placed 
in a 250ml capacity conical flask. Then 1 OOml of IX T AE was added into the flask and the 
agarose powder was dissolved with brief mixing. It was then boiled for 3 minutes in 
microwave. Once it was completely dissolved, the flask was allowed to cool to 50°C before 
addition of 0.5J.!l of Ethidium bromide (lOmg/ml). The solution was mixed well and 
immediately poured into the agarose gel tray which was pre-assembled with desirable gel 
comb. 
4.4 Running of agarose gel electrophoresis 
After the agarose gel polymerized, it was transferred to an electrophoresis tank filled 
with IX TAE buffer. The DNA sample to be visualized was placed in a new tube and added 
with gel loading buffer in 1:5 ratio. After gentle mixing, the samples were loaded into the 
wells of the gel. 4Jll of the molecular weight marker (lOObp or lkb ladder) were loaded as 
well. The gel must submerge fully beneath the buffer and electrophoresis was run at 1 OOV for 
1 hour. When completed, the DNA bands were visualized under UV transilluminator. The 
Ethidium bromide added to the gel will intercalate with the DNA and upon exposure to uv 
light, the DNA fluores as orange bands. 
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4.5 Gel elution 
After visualization with the UV transilluminator, the desired band of DNA can be 
eluted from the gel for further manipulation. In this study, the elution was carried out by using 
the UL TRAFREE-DA kit from Milipore. The agarose gel containing the desired DNA was 
carefully cut out with a sterile surgical blade and transferred into the elution tube. The tube 
was then centrifuged at 12,000tpm for 15 minutes at room temperature. Within the tube 
contained a filter which separates the DNA from the gel. The eluted DNA is stored at -20°C 
for further manipulation. 
5. Ligation 
5.1 Principle and methodology of ligation 
Ligation of DNA occurs when two DNA termini are covalently linked to each other 
with the help of T4 DNA ligase. The T4 DNA ligase is an enzyme which catalyses the 
synthesis of phosphodiester bond between the 3 '-hydroxyl and 5 '-phosphoryl ends of DNA. It 
requires the Mg2+ and A TP as co-factors. 
In this study, the T4 DNA ligase from Fermentas, USA was used. There are two 
different methods of ligation, namely the blunt end ligation and the sticky end ligation. Both 
methods were used in this study. 
For blunt end self-ligation of the linearized vector, all the contents mentioned in Table 
4 were added into a microcentrifuge tube, briefly vortex and spin down. The reaction was then 
incubated at 16°C (lower compartment of refrigerator) for overnight. On the next day, IJ.!l of 
T4 DNA ligase was added and incubated at room temperature for another hour. The ligation 
mix was then ready for transformation. 
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As for the sticky end ligation, the restricted vector and insert as well as distilled water 
(Table 5) were added into a clean microcentrifuge tube and incubated at 56°C for 5 minutes. 
Following this 1 OX ligation buffer and T4 DNA ligase were added and incubated at 16°C 
(lower compartment of refrigerator) for overnight. On the next day, 1 J.ll of T4 DNA ligase 
was added and incubated at room temperature for another hour. The ligation mix was ready 
for transformation. 
Table 4: Blunt end ligation of linearized pTOP02.1-recA (self-ligation) 
Contents Volume 
Linearized pTOP02.1-recA 5 J.ll 
1 OX ligation buffer 2 J.ll 
T4 DNA ligase 1 J.ll 
Distilled water 12 J.ll 
TOTAL 20p.d 
Table 5: Sticky end ligation of restricted vector and insert 
Contents Volume 
Vector 2 J.ll 
Insert 10 J.ll 
1 OX ligation buffer 2 J.ll 
T4 DNA ligase 1 J.tl 




6.1 Principle of transformation 
Transformation is a process whereby bacteria can uptake foreign DNA from the 
environment. For transformation to occur, the bacteria need to be 'competence'. Some 
bacteria are naturally competence and readily undergo transformation, for instance the 
Haemophilus, Bacillus, Neisseria, Escherichia species and etc. On the other hand, the 
transformation can also be induced by making the bacteria 'competence'. This can be done 
via physical or chemical induction. The most common method used are Calcium chloride 
method, Polyethylene glycol method or by electroporation. 
6.2 Methodology of competent cell preparation 
For Calcium chloride method, a single isolated colony from freshly streaked plate was 
inoculated into 2ml LB plain broth and incubated at 37°C in the static condition. On the next 
day, 300J!l of the overnight culture were taken and inoculated into a 5 Oml LB broth. The 
culture was incubated in the shaker (250rpm, 37°C) for 3 to 4 hours. As the bacterial growth 
reached an optical density (OD 600nm) of 0.5, the culture was immediately put on ice to stop 
the growth. It was then centrifuged at 3000 rpm at 4°C for 10 minutes. The supernatant was 
discarded and the pellet was gently resuspended with 6 m1 of ice-cold 1 OOmM Magnesium 
chloride. It was then incubated in ice for 45 minutes. 
Then, the suspension was again centrifuged at 3000 rpm at 4°C for 10 minutes. The 
supernatant was discarded and the pellet was gently resuspended with 3ml of ice-cold 1 OOmM 
Calcium chloride. Both the chemicals altered the permeability of bacterial cell membrane and 
making it competence for transformation. 
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The competent cells can be used immediately for transformation. If storage is desired, 
450J!l of glycerol (15% of the 3ml competent cell suspension) is added to the competent cell 
as cryopreservative and aliquoted 150J!l each into sterile microcentrifuge tube for storage at -
70 °c. 
The growth of bacteria was strictly monitored so as not to exceed 0.5 (00600) and the 
entire preparation was carried out on ice as the cells were extremely sensitive against heat. 
6.3 Methodology of transformation 
For the Calcium chloride method of transformation, the suitable volume of ligation 
mixture or plasmid to be transformed was added into the competent cells and incubated on ice 
for 20 minutes. Then, heat shock was given to the cells by incubating the tube at 42°C for 30 
to 45 seconds. This step is important to increase the permeability of cell by opening up the 
pores of membrane. Then the tube was immediately placed on ice and kept for 2 minutes. 
This is another critical step and the transfer to ice should be quickly done as prolong heating 
would kill the cells. Next, 350fll of fresh LB broth was added into the tube and incubated at 
37°C for 1 hour. The LB broth was added to provide nutrient to the cells for recovery from the 
heat shock. During incubation, any plasmid which successfully transformed into the 
competent cells would express the antibiotic marker gene for selection of successful 
transformation later. After incubation, an appropriate amount of cells was inoculated on LB 
agar containing antibiotics which corresponding to the antibiotic marker gene in plasmid. The 
plates were incubated overnight at 37°C. 
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7. Patching and lysate preparation 
A successful transformation on the LB agar must be further confirmed for the insert of 
interest. For this reason, around 12 colonies were chosen randomly from the plate and patched 
on a freshly prepared agar plate added with the same corresponding antibiotic. This was done 
to maintain the isolated colony as a stock for further use in future. 
Patching was done by touching the colony with a stab inoculating wire and inoculated 
on the LB agar, as shown in Figure I. After patching, the same loop was suspended in 20f.ll of 
distilled water in a 0.5ml tube for the lysate preparation. Then, the lysate was added with 2 
drops of mineral oil and boiled at I OOOC for I 0 minutes. The content was then briefly spun 
down and 2fJ.l from the lysate was used as template for PCR screening to confirm the insert of 
interest. 
+ + 
3 4 5 
+ + 7 8 9 
Figure I : Patching on the LB agar 
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